Tag Archives: Foamix Pharmaceuticals Ltd.

Week’s opening stock roundup: Impax, Omeros shine; Foamix down, but not out

1) Impax Laboratories Inc. (Nasdaq:IPXL) led advancing issues, rocketing $3.40, or 37% over the week, to $12.65. The upward move came after the company reported it has hired Allergan PLC’s… Read more »